Novo Nordisk A/S (NVO) Expands Manufacturing to Support Rising Global Demand for GLP-1 Drugs

Novo Nordisk A/S (NYSE:NVO) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 2, Novo Nordisk A/S (NYSE:NVO) reiterated its plans to invest about $506 million to expand its manufacturing facility in Ireland. The investment will finance the expansion of production capacity for oral products, including various formulations of GLP-1 drugs. The expansion is also part of an effort to meet current and future demand outside the US. Construction of the manufacturing facility in Athlone, Irelan ...